Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DBV Technologies S.A. | 1,825 | reported | 06 Feb 2024 | tx 2+8,662 |
| ACADIA PHARMACEUTICALS INC | 0 | reported | 29 May 2026 | tx 20+146,005−32,908 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | — | |
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 16,004 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 9,311 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | — | |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 13,793 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 12 Oct 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 4,381 | — | |
| 12 Oct 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 4,381 | 0.00 USD | deriv |
| 29 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 6,652 | — | |
| 29 May 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 9,387 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 15,959 | 0.00 USD | deriv |
| 29 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 6,652 | 0.00 USD | deriv |
| 06 Feb 2024 | PURCHASE | DBV Technologies S.A. | 1,825 | 0.89 USD | first after silence |
| 12 Oct 2023 | EXERCISE | ACADIA PHARMACEUTICALS INC | 4,381 | — | |
| 12 Oct 2023 | EXERCISE | ACADIA PHARMACEUTICALS INC | 4,381 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 6,652 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 11,045 | 0.00 USD | deriv |
| 12 Oct 2022 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 14,077 | 0.00 USD | deriv |
| 12 Oct 2022 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 8,762 | 0.00 USD | deriv |
| 10 Jun 2021 | PURCHASE | DBV Technologies S.A. | 6,837 | 7.12 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 06 Feb 2024.